Cargando…

(Oral) enoximone in asthma

PDE-3 inhibitors appear to have a large therapeutic value in asthma treatment; this letter provides some of the insights acquired in recent research https://bit.ly/33D9Dgd

Detalles Bibliográficos
Autor principal: Beute, Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7682675/
https://www.ncbi.nlm.nih.gov/pubmed/33263042
http://dx.doi.org/10.1183/23120541.00319-2020
_version_ 1783612727378313216
author Beute, Jan
author_facet Beute, Jan
author_sort Beute, Jan
collection PubMed
description PDE-3 inhibitors appear to have a large therapeutic value in asthma treatment; this letter provides some of the insights acquired in recent research https://bit.ly/33D9Dgd
format Online
Article
Text
id pubmed-7682675
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher European Respiratory Society
record_format MEDLINE/PubMed
spelling pubmed-76826752020-11-30 (Oral) enoximone in asthma Beute, Jan ERJ Open Res Correspondence PDE-3 inhibitors appear to have a large therapeutic value in asthma treatment; this letter provides some of the insights acquired in recent research https://bit.ly/33D9Dgd European Respiratory Society 2020-11-02 /pmc/articles/PMC7682675/ /pubmed/33263042 http://dx.doi.org/10.1183/23120541.00319-2020 Text en Copyright ©ERS 2020 http://creativecommons.org/licenses/by-nc/4.0/This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.
spellingShingle Correspondence
Beute, Jan
(Oral) enoximone in asthma
title (Oral) enoximone in asthma
title_full (Oral) enoximone in asthma
title_fullStr (Oral) enoximone in asthma
title_full_unstemmed (Oral) enoximone in asthma
title_short (Oral) enoximone in asthma
title_sort (oral) enoximone in asthma
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7682675/
https://www.ncbi.nlm.nih.gov/pubmed/33263042
http://dx.doi.org/10.1183/23120541.00319-2020
work_keys_str_mv AT beutejan oralenoximoneinasthma